Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Change in Inventory (2019 - 2025)

AVITA Medical (RCEL) has disclosed Change in Inventory for 5 consecutive years, with -$198000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Inventory fell 117.69% year-over-year to -$198000.0, compared with a TTM value of $468000.0 through Dec 2025, down 78.33%, and an annual FY2025 reading of $468000.0, down 78.33% over the prior year.
  • Change in Inventory was -$198000.0 for Q4 2025 at AVITA Medical, down from -$144000.0 in the prior quarter.
  • Across five years, Change in Inventory topped out at $1.7 million in Q1 2024 and bottomed at -$629000.0 in Q2 2025.
  • Average Change in Inventory over 4 years is $418250.0, with a median of $250500.0 recorded in 2022.
  • The sharpest move saw Change in Inventory soared 1992.54% in 2023, then crashed 225.3% in 2024.
  • Year by year, Change in Inventory stood at $252000.0 in 2022, then surged by 411.11% to $1.3 million in 2023, then fell by 13.12% to $1.1 million in 2024, then tumbled by 117.69% to -$198000.0 in 2025.
  • Business Quant data shows Change in Inventory for RCEL at -$198000.0 in Q4 2025, -$144000.0 in Q3 2025, and -$629000.0 in Q2 2025.